title: The immunogenic potential of generic version of low-molecular-weight heparins may not be the same as the branded products.
authors.forename: Jawed
authors.initials: J
authors.lastname: Fareed
authors.forename: Rodger L
authors.initials: RL
authors.lastname: Bick
authors.forename: Gundu
authors.initials: G
authors.lastname: Rao
authors.forename: Samuel Z
authors.initials: SZ
authors.lastname: Goldhaber
authors.forename: Arthur
authors.initials: A
authors.lastname: Sasahara
authors.forename: Harry L
authors.initials: HL
authors.lastname: Messmore
authors.forename: Debra A
authors.initials: DA
authors.lastname: Happensteadt
authors.forename: Andrew
authors.initials: A
authors.lastname: Nicolaides
mesh_terms: D000917:Antibody Formation; D016568:Drugs, Generic / Q000009:adverse effects / Q000592:standards*; D006495:Heparin, Low-Molecular-Weight / Q000276:immunology*; D006801:Humans; D013921:Thrombocytopenia / Q000139:chemically induced / Q000276:immunology
chemical_list: D016568:Drugs, Generic; D006495:Heparin, Low-Molecular-Weight